BRAF and colorectal carcinoma: In the present study, we provide the unprecedented findings, observed in xenogeneic BRAFV600E CRC and, most important, confirmed in patients harbouring BRAF mutation, that a distinctive microbiota profile could distinguish BRAF-mutated cases among CRCs.